| Execution period | Vesting over 5 years |
|---|
NSE filing, NSE: VSSL. Summary written from the filing by ALFA Finder's alert engine.
Vardhman Special Steels Ltd: key numbers
- Share price
- ₹328.70
- Market cap
- ₹3,181 Cr
- Revenue (annual)
- ₹1,754 Cr
- Net profit (annual)
- ₹122.0 Cr
- P/E (TTM)
- 19.7×Sector 16.7×
- Promoter holding
- 51.18%+0.12% QoQ
- FII holding
- 0.58%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Vardhman Special Steels Ltd
All →Vardhman Special Steels Earnings Call Transcript: Key Takeaways
Strong quarterly performance driven by robust demand and operational efficiencies, though management warns current high EBITDA levels are unsustainable.
Vardhman Special Steels Investor Presentation: Key Takeaways
Q2 FY27 revenue ₹600.05 Cr (+38.8% YoY), PAT ₹52.49 Cr (+51.9%), EBITDA ₹83.86 Cr; H1 PAT +72%. Strategy: forging line (₹475 Cr) and ~₹2,600 Cr capex.
Vardhman Special Steels Results Update
Vardhman Special Steels posted H1 FY27 revenue of ₹1,086.06 Crore and PAT of ₹93.68 Crore. Q2 profit rose 51.88% year on year.
Vardhman Special Steels Management Change
Vardhman Special Steels appointed Mr. Iwao Shimamoto as Non-Executive Non-Independent Director effective 27 October 2026. The board move follows the May 2025 Share Subscription Agreement with Aichi Steel Corporation.
Vardhman Special Steels Q2 FY27 Results: Net Profit ₹52.5 Cr, Up 51.7% YoY
Vardhman Special Steels Ltd reported revenue from operations of ₹600.1 Cr (+38.8% YoY) and net profit of ₹52.5 Cr (+51.7% YoY) for Q2 FY27.
- Key figure
- Net profit ₹52.5 Cr · +51.7% YoY
Vardhman Special Steels Board Meeting Date
Vardhman Special Steels Limited scheduled a board meeting on October 27, 2026. The board will consider and approve un-audited financial results for the quarter ended September 30, 2026.
Other employee stock options announcements
All →RateGain Travel Technologies Employee Stock Options
RateGain granted 53,021 Stock Appreciation Rights under its SAR Scheme 2022 at ₹800 and ₹862.25 per unit. The grants vest over four years and are exercisable within three years of vesting.
- Execution
- Vesting over 4 years (10% Y1, 20% Y2, 30% Y3, 40% Y4); exercisable within 3 years of vesting
Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.